pleas
cite
articl
press
jacqu
et
al
synergist
interferonc
product
induc
mous
hepat
viru
natur
killer
cell
modul
carcinoembryon
antigenrel
cell
adhes
molecul
ceacam
receptor
immunolog
natur
killer
nk
cell
import
arm
innat
immun
virusinfect
cell
bacteria
tumour
cell
exert
direct
cytotox
function
well
indirect
antivir
function
secret
interferonc
ifnc
role
intrahepat
nk
cell
outcom
human
viral
hepat
fulli
understood
nk
cell
known
act
first
line
control
mani
viral
infect
herp
simplex
viru
type
epsteinbarr
viru
human
herpesviru
murin
cytomegaloviru
howev
human
hepat
c
viru
develop
strategi
evad
detect
elimin
nk
cell
also
suggest
increas
number
nk
cell
liver
patient
immunotoler
phase
chronic
hepat
b
viru
infect
liver
enrich
nk
nkt
cell
play
major
role
control
viral
hepat
infect
limit
viral
replic
via
ifncdepend
mechan
recent
sever
studi
demonstr
import
cytotox
activ
nk
cell
prevent
establish
chronic
human
hepat
c
viru
infect
natur
killer
cell
rapidli
recruit
bone
marrow
spleen
viral
infect
ifnc
enhanc
cytotox
activ
nk
cell
increas
product
ifnc
cell
moreov
product
ifnc
nk
cell
stimul
depend
activ
immunoreceptor
tyrosinebas
activ
motif
itam
regul
extracellular
signalregul
mitogenactiv
protein
kinas
mapk
pathway
howev
littl
known
mechan
involv
effici
product
antivir
ifnc
intrahepat
nk
cell
acut
phase
viral
hepat
mous
hepat
viru
mhv
excel
model
studi
immunolog
disord
associ
viral
product
interferonc
ifnc
infiltr
natur
killer
nk
cell
liver
involv
control
mous
hepat
viru
mhv
infect
object
studi
identifi
mechan
use
mhv
type
modul
product
ifnc
nk
cell
acut
hepat
suscept
mice
ex
vivo
vitro
experi
reveal
nk
cell
express
carcinoembryon
antigenrel
cell
adhes
molecul
ceacam
mhv
receptor
produc
higher
level
ifnc
presenc
synergist
product
ifnc
nk
cell
depend
viral
replic
rather
viral
fixat
inhibit
induc
cell
infect
ultravioletinactiv
virus
cell
mice
infect
virul
virus
synergist
ifnc
product
involv
mitogenactiv
protein
kinas
mapk
rather
extracellular
signalregul
mapk
signal
pathway
howev
signal
trigger
engag
decreas
product
ifnc
molecul
crosslink
use
specif
monoclon
antibodi
result
suggest
control
acut
hepat
ifncproduc
nk
cell
may
depend
product
liver
environ
viral
infect
nk
cell
keyword
coronaviru
hepat
interferonc
mitogenactiv
protein
kinas
natur
killer
cell
hepat
hepatotrop
serotyp
induc
acut
chronic
hepat
accord
strain
age
immun
statu
mous
moreov
replic
hepatocyt
liver
sinusoid
endotheli
cell
lsec
kupffer
cell
kc
lead
virusinduc
cell
death
result
fulmin
hepat
suscept
mice
death
within
day
postinfect
pi
previous
report
develop
hepat
pathogen
mice
relat
decreas
splenic
myeloid
nk
cell
format
syncytia
subsequ
apoptosi
moreov
vivo
deplet
nk
cell
mhv
infect
enhanc
viru
replic
turn
lead
pronounc
hepat
contrast
low
decreas
nk
cell
detect
mice
infect
attenu
viru
variant
suggest
protect
role
nk
cell
hepat
interferonc
known
play
protect
role
hepat
induc
variou
mhv
serotyp
studi
target
effici
nk
cell
function
mhv
infect
recent
report
enhanc
protect
mice
correl
increas
ifnc
product
infiltr
nk
cell
within
brain
liver
furthermor
addit
mice
suscept
infect
led
increas
ifnc
product
liver
better
control
infect
although
ifncproduc
cell
involv
identifi
infect
suscept
cell
mhv
depend
fixat
viral
surfac
protein
receptor
identifi
carcinoembryon
antigenrel
cell
adhes
molecul
shown
homotyp
interact
nk
cell
variou
target
cell
inhibit
nk
cell
cytotox
addit
engag
lead
inhibit
tcell
prolifer
ifnc
product
nkt
cell
contrast
tolllik
receptordepend
activ
nuclear
factorjb
upregul
express
wherea
ifnc
downregul
decreas
permiss
suscept
cell
mhv
infect
express
surfac
hepat
cell
includ
lsec
kc
hepatocyt
b
nk
cell
scarc
express
naiv
cell
report
mapk
pathway
activ
periton
macrophag
infect
within
first
min
infect
suggest
effect
occur
respons
fixat
viru
receptor
also
suggest
replic
viru
depend
activ
mapk
pathway
without
identifi
replic
step
involv
respect
effect
engag
mhv
surfac
protein
activ
mapk
pathway
antivir
function
nk
cell
remain
unknown
fact
mice
resist
infect
suggest
absolut
requir
viral
infect
work
demonstr
synergist
product
ifnc
nk
cell
presenc
involv
viral
replic
mapk
signal
pathway
decreas
engag
wildtyp
mice
purchas
charl
river
laboratori
st
constant
qc
canada
knockout
mice
gener
dr
n
beauchemin
previous
describ
anim
certifi
manufactur
hous
hepafilt
air
forma
scientif
marietta
oh
femal
mice
week
age
use
experi
studi
conduct
complianc
regul
anim
committe
du
montreal
uqam
pathogen
viru
clone
substrain
isol
liver
infect
mice
propag
cell
previous
describ
pathogen
properti
viru
assess
regularli
group
three
six
mice
accord
experi
infect
intraperiton
rout
tissu
cultur
infect
dose
tcid
mockinfect
mice
receiv
similar
volum
gibco
laboratori
grand
island
ny
hr
infect
mice
anaesthet
intraperiton
inject
use
ketamin
hydrochlorid
mgkg
vetrepharm
canada
inc
bellevil
canada
xylazin
mgkg
bayer
inc
toronto
canada
mice
bled
section
portal
vein
aortic
arteri
liver
harvest
follow
exsanguin
intrahepat
mononuclear
cell
mnc
isol
describ
watanab
et
al
continu
mous
fibroblast
cell
line
grown
supplement
lglutamin
mm
antibiot
penicillin
uml
streptomycin
mgml
gibco
laboratori
fetal
calf
serum
fc
cell
use
viral
product
intrahepat
mnc
isol
liver
mice
experiment
group
previous
describ
briefli
liver
press
lm
cell
strainer
falcon
scientif
co
montreal
qc
canada
wash
ml
supplement
fc
cell
suspens
deposit
ml
fc
allow
debri
sediment
top
layer
recov
centrifug
min
g
supernat
collect
quantif
cytokin
enzymelink
immunosorb
assay
elisa
pass
lm
filter
sarstedt
inc
montreal
qc
canada
cell
suspens
deposit
top
discontinu
percol
gradient
percol
phosphatebuff
salin
pb
amersham
pharmacia
uppsala
sweden
gibco
laboratori
centrifug
min
g
mnc
collect
interfac
percol
layer
wash
supplement
fc
final
adjust
cellsml
myeloid
mnc
isol
femur
uninfect
mice
briefli
femur
soak
ethanol
min
wash
subsequ
supplement
fc
femur
excis
surround
muscl
tissu
marrow
flush
use
syring
fill
supplement
fc
fit
needl
calibr
becton
dickinson
co
franklin
lake
nj
cell
suspens
thereaft
purifi
lymphoprep
gradient
cedarlan
hornbi
canada
wash
adjust
cellsml
intrahepat
myeloid
nk
cell
elimin
posit
select
use
pan
nk
antibodi
coupl
microbead
stemcel
technolog
vancouv
bc
canada
total
myeloid
mnc
purifi
cell
mnc
resuspend
supplement
fc
adjust
cellsml
experi
cell
viabil
rang
assay
trypan
blue
exclus
test
intrahepat
mnc
isol
six
mockor
mice
hr
infect
seed
plate
concentr
cellsml
supplement
fc
recombin
murin
biosourc
montreal
qc
canada
ad
final
concentr
ngml
respect
cell
incub
co
hr
supernat
collect
ifnc
quantif
elisa
mnc
isol
liver
bone
marrow
uninfect
wildtyp
mice
cell
thereaft
seed
plate
concentr
cellsml
supplement
fc
recombin
ad
final
concentr
ngml
respect
experi
specif
mapk
inhibitor
calbiochem
san
diego
ca
ad
final
concentr
lgml
differ
concentr
sodium
stiboglucon
ss
also
ad
min
inhibit
phosphatas
monoclon
murin
antibodi
produc
rat
affinitypurifi
hitrap
protein
g
column
also
ad
concentr
cell
cell
infect
multipl
infect
infecti
treat
hr
ultraviolet
uv
light
incub
co
hr
supernat
collect
ifnc
quantif
elisa
percent
intrahepat
tcrbcell
vivo
mockor
mice
determin
doubl
immunolabel
intrahepat
mnc
isol
cell
resuspend
ml
pb
incub
ice
presenc
blocker
pharmingen
toronto
canada
min
thereaft
cell
incub
min
lg
fluorescein
isothiocyanateconjug
clone
mous
immunoglobulin
pharmingen
lg
phycoerythrinconjug
tcell
receptorb
tcrb
clone
armenian
hamster
pharmingen
cell
wash
pb
fix
overnight
pb
ph
contain
formaldehyd
fisher
scientif
co
canada
flow
cytometr
analys
perform
fluorescenceactiv
cell
flow
cytomet
facscan
cell
quest
softwar
bectondickinson
moutain
view
ca
ten
thousand
cell
analys
per
sampl
percentag
tcrbcell
determin
multiparametr
analysi
interferonc
level
produc
supernat
ex
vivo
vitro
infect
liver
extract
determin
use
mous
mous
mous
ifnc
bd
opteia
elisa
set
bd
bioscienc
mississauga
canada
vivo
ex
vivo
studi
statist
analys
perform
use
analysi
varianc
anova
test
vitro
studi
statist
analys
perform
use
student
ttest
statist
comparison
calcul
graphpad
prism
softwar
graphpad
softwar
inc
la
jolla
ca
error
bar
repres
standard
error
valu
p
consid
signific
infect
synerg
product
ifnc
intrahepat
mnc
presenc
verifi
abil
intrahepat
mnc
mice
produc
ifnc
acut
phase
hepat
intrahepat
mnc
six
mockor
mice
isol
hr
infect
activ
ex
vivo
hr
level
ifnc
evalu
cell
supernat
shown
fig
section
unstimul
intrahepat
mnc
isol
mice
produc
slightli
ifnc
cell
mockinfect
mice
p
addit
howev
increas
product
ifnc
mnc
mockinfect
mice
p
verifi
viral
infect
involv
product
ifnc
intrahepat
mnc
cell
isol
uninfect
mice
infect
vitro
hr
presenc
ifnc
releas
cell
supernat
quantifi
shown
fig
section
ii
infect
intrahepat
mnc
induc
low
signific
ifnc
product
p
addit
p
p
p
uninfect
intrahepat
mnc
increas
ifnc
product
fig
section
ii
ii
b
product
ifnc
intrahepat
mnc
howev
synergist
increas
cell
simultan
treat
vitro
cytokin
p
treatment
compar
uninfect
treat
cell
fig
section
ii
ii
b
result
indic
act
synergi
one
suscept
cell
type
present
intrahepat
mnc
cultur
uninfect
mice
produc
ifnc
nk
cell
respons
product
ifnc
respons
combin
treatment
previous
demonstr
product
ifnc
liver
respons
administr
depend
nk
cell
howev
intrahepat
nk
cell
recruit
liver
bone
marrow
spleen
mice
number
nk
cell
express
receptor
significantli
higher
bone
marrow
compar
spleen
liver
bone
marrow
mnc
use
sourc
nk
cell
mnc
bone
marrow
isol
nk
cell
thereaft
purifi
antibodi
coupl
microbead
total
myeloid
mnc
purifi
cell
prepar
puriti
cell
prepar
cell
remain
infect
vitro
presenc
shown
tabl
low
ifnc
produc
total
myeloid
mnc
infect
treat
howev
addi
tion
cytokin
myeloid
mnc
induc
synergist
product
ifnc
compar
untreat
cell
p
uninfect
cell
p
signific
ifnc
produc
uninfect
myeloid
mnc
treat
suggest
nk
cell
cell
involv
product
ifnc
purifi
cell
produc
ifnc
stimul
p
compar
untreat
cell
respond
synergist
manner
infect
p
compar
cell
result
indic
nk
cell
involv
synergist
product
ifnc
induc
cytokin
verifi
product
ifnc
nk
cell
treat
initi
viral
replic
cell
mice
specif
mhv
receptor
compar
wildtyp
mice
myeloid
mnc
wildtyp
mice
infect
vitro
hr
presenc
ifnc
level
supernat
quantifi
result
reveal
ifnc
induc
myeloid
mnc
mice
treat
infect
tabl
addit
viral
protein
detect
myeloid
nk
cell
mice
follow
doubl
immunolabel
use
antibodi
indic
viral
replic
occur
cell
failur
cell
produc
ifnc
suggest
viral
fixat
viral
replic
essenti
respons
role
viral
replic
verifi
use
uvinactiv
virus
myeloid
mnc
wildtyp
mice
infect
infecti
uvinactiv
presenc
level
ifnc
thereaft
determin
supernat
hr
pi
shown
fig
section
iii
product
ifnc
strongli
decreas
uvinactiv
ad
cell
presenc
p
absenc
viral
translat
myeloid
nk
cell
infect
uvinactiv
virus
also
confirm
doubl
immunolabel
use
antibodi
intracellular
viral
protein
detect
howev
bone
marrow
mnc
treat
hr
infect
viru
synergist
ifnc
product
fail
occur
data
shown
indic
cellular
signal
pathway
involv
respons
may
simultan
activ
cytokin
first
step
viral
replic
mapk
pathway
rather
mapk
involv
synergist
ifnc
product
nk
cell
mapk
pathway
mainli
involv
product
ifnc
nk
cell
stimul
moreov
unidentifi
earli
step
mhv
replic
also
depend
activ
mapk
pathway
wherea
engag
predominantli
induc
mapk
pathway
verifi
ifnc
respons
depend
andor
mapk
pathway
total
bone
marrow
mnc
purifi
cell
puriti
wildtyp
mice
treat
hr
specif
inhibitor
mapk
thereaft
infect
presenc
ifnc
level
quantifi
hr
pi
shown
tabl
product
ifnc
total
bone
marrow
mnc
treat
significantli
decreas
presenc
mapk
inhibitor
p
compar
cell
treat
cytokin
effect
conserv
purifi
myeloid
cell
fraction
p
mapk
inhibitor
mapk
inhibitor
induc
effect
known
crosslink
homotyp
interact
essenti
induc
inhibitori
respons
nk
nkt
cell
therefor
studi
crosslink
monoclon
antibodi
could
provid
effect
verifi
first
specif
antibodi
induc
inhibit
synergist
ifnc
product
presenc
result
shown
coat
plate
hr
myeloid
mnc
wildtyp
seed
infect
presenc
ifnc
level
quantifi
hr
pi
shown
fig
section
iii
b
synergist
ifnc
product
inhibit
coat
suggest
crosslink
downregul
synergist
respons
induc
presenc
compet
viral
fixat
receptor
p
compar
treatment
plu
support
hypothesi
engag
downregul
ifnc
respons
bone
marrow
mnc
wildtyp
mice
treat
differ
concentr
phosphatas
inhibitor
ss
involv
inhibitori
signal
pathway
viral
replic
infect
presenc
ifnc
level
thereaft
quantifi
hr
pi
shown
fig
section
iii
c
product
ifnc
increas
myeloid
cell
treat
phosphatas
inhibitor
concentr
rang
lgml
p
lgml
p
lgml
result
support
inhibitori
role
rather
neutral
viral
fixat
recent
demonstr
level
hepat
mice
infect
depend
viral
permiss
kc
lsec
involv
product
intrahepat
subsequ
ifnc
product
nk
cell
intrahepat
ifnc
level
evalu
elisa
test
liver
extract
six
mice
infect
tcid
hr
pi
intrahepat
ifnc
induc
liver
mice
hr
pi
compar
mockinfect
mice
pgml
mice
absenc
ifnc
product
may
relat
inabl
hepat
cell
produc
adequ
level
effect
intrahepat
induc
mice
day
infect
compar
mockinfect
mice
pgml
mice
furthermor
intrahepat
level
decreas
mice
acut
hepat
mockinfect
mice
pgml
mice
pgml
p
cytokin
decreas
also
observ
earli
hr
pi
result
shown
addit
previous
report
nk
cell
mice
support
viral
replic
subsequ
apoptosi
verifi
decreas
ifnc
product
relat
apoptosi
intrahepat
nk
cell
acut
phase
viral
hepat
three
mice
infect
tcid
intrahepat
mnc
thereaft
isol
differ
time
pi
intrahepat
mnc
label
fluorescein
isothiocyanateconjug
phycoerythrinconjug
antitcrb
antibodi
analys
fluorometri
two
distinct
cell
popul
observ
accord
forwardsid
scatter
fscssc
paramet
normal
lymphoid
cell
character
normal
fsc
ssc
paramet
tunel
cell
wherea
apoptot
lymphoid
cell
character
lower
fsc
higher
ssc
paramet
confirm
tunel
test
posit
cell
intrahepat
tcrbcell
mice
underw
apoptosi
hr
pi
mockinfect
mice
mice
p
hr
pi
mockinfect
mice
mice
p
peak
hr
pi
mockinfect
mice
mice
p
studi
report
presenc
induc
synergist
ifnc
product
nk
cell
mice
effect
shown
depend
viral
replic
control
mapk
mapk
signal
pathway
howev
signal
trigger
engag
inhibit
synergist
product
ifnc
work
demonstr
induc
synergist
ifnc
respons
intrahepat
myeloid
mnc
presenc
absenc
properti
mainli
result
nk
cell
lost
nk
cell
deplet
wherea
purifi
nk
cell
exhibit
synergist
ifnc
respons
import
demonstr
role
nk
cell
product
ifnc
sinc
cell
nkt
cell
also
present
liver
andor
bone
marrow
sourc
ifnc
respons
treatment
howev
neither
cell
express
low
level
express
infect
hand
b
cell
may
infect
known
ifncproduc
cell
previous
report
nk
cell
new
cell
target
mhv
cell
express
viral
receptor
context
synergist
product
ifnc
nk
cell
presenc
coronaviru
requir
effect
nk
cell
mice
produc
ifnc
synergist
manner
respons
absenc
synergist
respons
cell
mice
result
function
anomali
nk
cell
signific
differ
intrahepat
lymphoid
cell
subpopul
nk
cell
function
observ
cell
mice
compar
wildtyp
mice
moreov
matur
defect
nk
cell
detect
bone
marrow
mice
compar
wildtyp
mice
unpublish
observ
dr
beauchemin
team
howev
result
suggest
may
induc
synergist
ifnc
product
independ
requir
molecul
enter
nk
cell
hypothesi
also
support
involv
viral
replic
rather
viral
fixat
demonstr
use
uvinactiv
mapk
inhibitor
addit
receptor
directli
trigger
product
ifnc
nk
cell
addit
specif
antibodi
induc
product
cytokin
bind
area
first
second
immunoglobulin
domain
howev
experi
use
plate
bound
antibodi
inhibitor
reveal
engag
receptor
activ
signal
pathway
turn
lead
inhibit
ifnc
product
nk
cell
presenc
receptor
exist
two
isoform
constitut
either
long
inhibit
cytoplasm
domain
contain
immunoreceptor
tyrosinebas
inhibitori
motif
itim
short
activ
cytoplasm
domain
possess
itim
itam
ortaldo
et
al
recent
demonstr
overrid
inhibitori
mechan
inhibitori
receptor
contain
itim
enabl
ifnc
product
author
nevertheless
notic
crosslink
activ
receptor
possess
itam
essenti
respons
receptor
alreadi
associ
inhibit
ifnc
product
human
nkt
cell
studi
may
play
inhibitori
role
crosslink
homotyp
interact
ifnc
product
nk
cell
hand
inhibit
associ
itim
increas
product
cytokin
may
therefor
involv
modul
ifnc
pathway
nk
cell
hypothes
high
number
viral
protein
produc
hepat
cell
may
bind
molecul
express
nk
cell
surfac
attenu
secret
ifnc
result
indic
synergist
respons
ifnc
nk
cell
presenc
complet
depend
mapk
pathway
mapk
pathway
therefor
link
viral
infect
nk
cell
activ
mediat
product
ifnc
nk
cell
stimul
depend
activ
itam
regul
mapk
pathway
pretreat
nk
cell
min
suffici
ifnc
induct
simultan
mapk
pathway
essenti
first
step
mhv
replic
wherea
mapk
pathway
predominantli
activ
observ
uvinactiv
fail
induc
ifnc
product
compar
infecti
indic
rnadepend
phase
viral
replic
rather
viral
fixat
receptor
involv
synergist
ifnc
product
uvinactiv
viru
may
bind
receptor
intern
induc
translat
viral
messeng
rna
effect
banerje
et
al
demonstr
uvinactiv
mhv
fail
activ
mapk
wherea
activ
mapk
cjun
termin
kinas
essenti
phosphoryl
translat
initi
factor
involv
enhanc
translat
rate
capcontain
messeng
rna
absenc
synergist
ifnc
product
observ
ad
interv
hr
pi
result
reinforc
implic
synergist
product
ifnc
nk
cell
occur
earli
stage
viral
replic
recent
barr
et
al
report
rapid
transient
activ
nk
cell
ifnc
product
follow
infect
herp
simplex
viru
type
result
releas
dendrit
cell
exclud
possibl
loss
synergist
product
ifnc
nk
cell
pretreat
hr
infect
may
consequ
impair
express
inde
ifnc
reduc
express
report
vassao
et
al
consequ
nk
cell
may
becom
resist
subsequ
fixat
turn
would
affect
ifnc
product
acut
phase
viral
infect
recruit
nk
cell
bone
marrow
spleen
affect
organ
gener
observ
sever
studi
demonstr
myeloid
splenic
nk
cell
essenti
acut
hepat
cell
determin
antivir
protect
induct
effici
antivir
respons
recruit
nk
cell
intrahepat
microenviron
must
adequ
activ
hepat
nk
cell
normal
coloc
site
express
viral
antigen
ifnc
infect
environ
may
allow
nk
cell
receiv
celltocel
celltomatrix
contact
signal
favour
ifnc
secret
nk
cell
differ
activ
depend
local
howev
recruit
nk
cell
liver
requir
activ
adequ
level
becom
high
produc
ifnc
known
liver
kc
produc
follow
variou
stimuli
activ
intrahepat
nk
nkt
cell
produc
ifnc
result
provid
agreement
previou
vivo
studi
report
treatment
suscept
mice
creat
state
significantli
increas
ifnc
product
howev
induc
liver
mice
prevent
synergist
ifnc
product
recruit
nk
cell
blackwel
publish
ltd
immunolog
addit
recruit
intrahepat
nk
cell
spleen
bone
marrow
may
infect
produc
infect
lsec
kc
lead
virusinduc
apoptosi
phenomenon
suscept
mice
acut
hepat
reflect
ineffici
innat
antivir
respons
low
ifnc
product
defici
product
apoptosi
nk
cell
apoptosi
intrahepat
recruit
nk
cell
previous
report
spleen
bone
marrow
addit
evad
mechan
innat
antivir
defenc
result
suggest
intrahepat
nk
cell
resist
mice
aj
mice
would
produc
effici
ifnc
respons
presenc
adequ
intrahepat
level
hand
hepat
nk
cell
also
exert
function
toler
environ
inde
immunosuppress
cytokin
transform
growth
factorb
determin
level
ifnc
inhibit
howev
recent
observ
immunosuppress
cytokin
decreas
liver
mice
mice
infect
attenu
kc
lsecand
kc
lsecviru
variant
inabl
intrahepat
nk
cell
produc
ifnc
may
relat
apoptosi
depend
viral
permiss
kc
lsec
replic
fact
viral
infect
kc
lsec
may
favour
viral
infect
nk
cell
cell
contact
observ
suggest
produc
vivo
kc
may
essenti
preserv
antivir
function
nk
cell
integr
lsec
favour
surviv
cell
recruit
liver
howev
synergist
product
ifnc
occur
first
step
viral
replic
kc
lsec
yet
infect
work
progress
identifi
step
viral
replic
involv
synergist
ifnc
product
nk
cell
role
hepatocyt
kc
lsec
intrahepat
function
nk
nkt
cell
